<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Cell Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Cell Biol</journal-id>
<journal-id journal-id-type="publisher-id">jcb</journal-id>
<journal-id journal-id-type="hwp">jcb</journal-id>
<journal-title-group>
<journal-title>The Journal of Cell Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9525</issn>
<issn pub-type="epub">1540-8140</issn>
<publisher>
<publisher-name>Rockefeller University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31645461</article-id>
<article-id pub-id-type="pmc">6891100</article-id>
<article-id pub-id-type="publisher-id">201904148</article-id>
<article-id pub-id-type="doi">10.1083/jcb.201904148</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
<subj-group>
<subject>Report</subject>
</subj-group>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>19</subject>
<subject>23</subject>
<subject>43</subject>
<subject>41</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitochondrial stress causes neuronal dysfunction via an ATF4-dependent increase in L-2-hydroxyglutarate</article-title>
<alt-title alt-title-type="short">L-2-hydroxyglutarate causes neuronal dysfunction</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7516-215X</contrib-id>
<name>
<surname>Hunt</surname>
<given-names>Rachel J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-2767-9880</contrib-id>
<name>
<surname>Granat</surname>
<given-names>Lucy</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0376-5327</contrib-id>
<name>
<surname>McElroy</surname>
<given-names>Gregory S.</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ranganathan</surname>
<given-names>Ramya</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chandel</surname>
<given-names>Navdeep S.</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0754-1785</contrib-id>
<name>
<surname>Bateman</surname>
<given-names>Joseph M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor2"></xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Maurice Wohl Clinical Neuroscience Institute, King’s College London, London, UK</institution>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Department of Medicine and Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL</institution>
</aff>
<author-notes>
<corresp id="cor2">Correspondence to Joseph M. Bateman: <email>joseph_matthew.bateman@kcl.ac.uk</email></corresp>
<corresp id="PC_corhKyLA3RrHH">Navdeep S. Chandel: <email>nav@northwestern.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>02</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>10</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>218</volume>
<issue>12</issue>
<fpage>4007</fpage>
<lpage>4016</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 Hunt et al.</copyright-statement>
<copyright-year>2019</copyright-year>
<ali:free_to_read start_date="2020-06-01" xmlns:ali="http://www.niso.org/schemas/ali/1.0/"></ali:free_to_read>
<license license-type="open-access">
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is available under a Creative Commons License (Attribution 4.0 International, as described at <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<self-uri xlink:href="JCB_201904148_thumb.gif" xlink:role="icon"></self-uri>
<self-uri content-type="reviewer_comments" xlink:href="JCB_201904148_review_history.pdf"></self-uri>
<abstract abstract-type="precis">
<p>Hunt et al. show that mitochondrial stress in <italic>Drosophila</italic> neurons activates ATF4 expression, resulting in increased L-2-hydroxyglutarate (L-2-HG) levels. Reducing L-2-HG levels improves neuronal activity, demonstrating that increased L-2-HG contributes to neuronal dysfunction.</p>
</abstract>
<abstract>
<p>Mitochondrial stress contributes to a range of neurological diseases. Mitonuclear signaling pathways triggered by mitochondrial stress remodel cellular physiology and metabolism. How these signaling mechanisms contribute to neuronal dysfunction and disease is poorly understood. We find that mitochondrial stress in neurons activates the transcription factor ATF4 as part of the endoplasmic reticulum unfolded protein response (UPR) in <italic>Drosophila</italic>. We show that ATF4 activation reprograms nuclear gene expression and contributes to neuronal dysfunction. Mitochondrial stress causes an ATF4-dependent increase in the level of the metabolite L-2-hydroxyglutarate (L-2-HG) in the <italic>Drosophila</italic> brain. Reducing L-2-HG levels directly, by overexpressing L-2-HG dehydrogenase, improves neurological function. Modulation of L-2-HG levels by mitochondrial stress signaling therefore regulates neuronal function.</p>
</abstract>
<funding-group>
<award-group id="sp1">
<funding-source>Alzheimer’s Research UK</funding-source>
<award-id rid="sp1">ARUK-IRG2017A-2</award-id>
</award-group>
<award-group id="sp2">
<funding-source>
<institution-wrap>
<institution>Medical Research Council</institution>
<institution-id institution-id-type="DOI">https://doi.org/10.13039/501100000265</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="sp2">MR/N013700/1</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">
<institution-wrap>
<institution>King's College London</institution>
<institution-id institution-id-type="DOI">https://doi.org/10.13039/501100000764</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="sp4">
<funding-source>
<institution-wrap>
<institution>Medical Research Council</institution>
<institution-id institution-id-type="DOI">https://doi.org/10.13039/501100000265</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="sp5">
<funding-source>
<institution-wrap>
<institution>Guy’s and St Thomas’ Charity</institution>
<institution-id institution-id-type="DOI">https://doi.org/10.13039/501100000380</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="sp6">
<funding-source>
<institution-wrap>
<institution>National Institutes of Health</institution>
<institution-id institution-id-type="DOI">https://doi.org/10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="sp6">AG049665-04</award-id>
<award-id rid="sp6">T32CA9560-32</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>Mitochondria play key roles in cellular metabolism including synthesis of ATP, amino acids, reactive oxygen species (ROS), nucleotides, heme, and cholesterol (<xref ref-type="bibr" rid="bib38">Spinelli and Haigis, 2018</xref>). Efficient mitochondrial function is paramount in the nervous system, and mitochondrial diseases frequently result in motor dysfunction, seizures, ataxia, and intellectual disability. Compromised mitochondrial function is also a trait of common neurological diseases including neurodegenerative conditions, autism spectrum disorders, and schizophrenia (<xref ref-type="bibr" rid="bib19">Khacho et al., 2019</xref>).</p>
<p>Defects in mitochondrial gene expression cause imbalance of mitochondrial/nuclear encoded oxidative phosphorylation (OXPHOS) subunits and failure to correctly assemble OXPHOS complexes. The resulting mitochondrial stress triggers mitonuclear signaling mechanisms that enable mitochondria to communicate with the nucleus and reprogram nuclear gene expression (<xref ref-type="bibr" rid="bib3">Arnould et al., 2015</xref>). These signaling mechanisms include the mitochondrial unfolded protein response (UPR), mitochondrial proteolytic response, and heat shock response pathways. Mitochondrial stress in neurons reprograms metabolism and nuclear gene expression, potentially regulating neuronal function (<xref ref-type="bibr" rid="bib16">Hunt and Bateman, 2018</xref>). However, the mechanisms by which mitochondrial stress regulates neuronal function are poorly understood.</p>
</sec>
<sec id="s2" sec-type="results|discussion">
<title>Results and discussion</title>
<sec id="s3">
<title>Mitochondrial stress–induced activating transcription factor 4 (ATF4) causes neuronal dysfunction</title>
<p>To investigate how mitochondrial stress affects the nervous system, we used inducible overexpression of the mitochondrial transcription factor TFAM in <italic>Drosophila melanogaster</italic>. TFAM is an HMG box DNA binding protein that binds to the mitochondrial DNA light strand promotor in a complex with the mitochondrial RNA polymerase and TFB2M (<xref ref-type="bibr" rid="bib14">Hallberg and Larsson, 2011</xref>; <xref ref-type="bibr" rid="bib39">Stros et al., 2007</xref>). Non-specific binding of TFAM packages mitochondrial DNA into its nucleoid structure, at high levels repressing gene expression (<xref ref-type="bibr" rid="bib18">Kang et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Ylikallio et al., 2010</xref>). TFAM overexpression inhibits mitochondrial OXPHOS gene expression (<xref ref-type="bibr" rid="bib7">Cagin et al., 2015</xref>; <xref ref-type="bibr" rid="bib33">Pohjoismaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib44">Ylikallio et al., 2010</xref>), and in the nervous system causes mitochondrial and neuronal dysfunction and triggers mitonuclear stress signaling (<xref ref-type="bibr" rid="bib7">Cagin et al., 2015</xref>; <xref ref-type="bibr" rid="bib9">Chen et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Duncan et al., 2018</xref>; <xref ref-type="bibr" rid="bib41">Tsuyama et al., 2017</xref>).</p>
<p>ATF4 is activated by a variety of different mitochondrial stresses in mammalian cultured cells and in vivo (<xref ref-type="bibr" rid="bib8">Celardo et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Quirós et al., 2017</xref>), and persistent activation can be detrimental (<xref ref-type="bibr" rid="bib20">Khan et al., 2017</xref>). ATF4 is activated in animal models of Alzheimer’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia, which exhibit neuronal mitochondrial stress (<xref ref-type="bibr" rid="bib15">Hughes and Mallucci, 2019</xref>). We find that in keeping with its role in the developing eye in <italic>Drosophila</italic>, ATF4 is expressed in photoreceptor neurons (Fig. S1 A; <xref ref-type="bibr" rid="bib17">Kang et al., 2017</xref>), but is not normally expressed in the <italic>Drosophila</italic> larval or adult central nervous system (CNS; <xref ref-type="fig" rid="fig1">Fig. 1, A and C</xref>). Consistent with other mitochondrial stress models, TFAM overexpression in neurons causes activation of ATF4 expression in both the larval and adult CNS (<xref ref-type="fig" rid="fig1">Fig. 1, A–D</xref>; and Fig. S1, B and C).</p>
<fig fig-type="figure" id="fig1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p><bold>Mitochondrial stress signaling via ATF4 in neurons. (A–B′) </bold>ATF4 is not expressed in control larval neurons (A and A′), but its expression is activated in motor neurons overexpressing (o/e) TFAM (B and B<bold>′</bold>) using <italic>OK371-Gal4</italic>. ATF4 in white in A and B and magenta in A<bold>′</bold> and B<bold>′</bold>. CD8-GFP (green) marks motor neurons. <bold>(C and D)</bold> ATF4 is not expressed in the adult brain (C) but is activated in neurons overexpressing TFAM with <italic>nSyb-Gal4</italic> (D). <bold>(E and F)</bold> Knockdown of ATF4 alleviates the climbing (E) and wing inflation (F) defects caused by TFAM overexpression in motor neurons using <italic>D42-Gal4</italic>. Numbers of flies for wing inflation are in white. <bold>(G)</bold> Knockdown of ATF4 alleviates the pupal lethality caused by pan-neuronal TFAM overexpression with <italic>nSyb-Gal4</italic>. Number of pupal cases are in white. Controls are <italic>Gal4</italic> hemizygotes. Data in E are presented as mean ± SEM. <italic>n</italic> = 20 for all genotypes. ***, P &lt; 0.001.</p>
</caption>
<graphic xlink:href="JCB_201904148_Fig1"></graphic>
</fig>
<p>TFAM overexpression also causes loss of presynaptic mitochondria, a reduction in presynaptic active zones, reduced climbing ability in adult flies, and inhibition of wing inflation, which is regulated by activity-dependent neuropeptide release from the CCAP neurons (<xref ref-type="bibr" rid="bib7">Cagin et al., 2015</xref>; <xref ref-type="bibr" rid="bib12">Duncan et al., 2018</xref>). To determine the functional role of ATF4, we performed climbing and wing inflation assays on flies overexpressing TFAM together with ATF4 knockdown in neurons. Expression of an RNAi targeting a control heterologous gene (luciferase) does not affect the TFAM overexpression climbing and wing inflation phenotypes (Fig. S1, D and E). However, ATF4 knockdown (Fig. S1 F) alleviates the climbing and wing inflation defects caused by neuronal TFAM overexpression (<xref ref-type="fig" rid="fig1">Fig. 1, E and F</xref>). Moreover, pan-neuronal overexpression of TFAM causes almost complete late pupal lethality, but knockdown of ATF4 in combination with TFAM overexpression significantly improves viability (<xref ref-type="fig" rid="fig1">Fig. 1 G</xref>). Therefore, ATF4 contributes to the reduced neuronal activity caused by mitochondrial stress.</p>
</sec>
<sec id="s4">
<title>Mitochondrial stress reprograms neuronal metabolism</title>
<p>We next characterized the gene expression changes caused by neuronal mitochondrial stress, and assessed the contribution of ATF4. Transcriptomic analysis of nervous system tissue showed that pan-neuronal TFAM overexpression significantly misregulates 87 genes with a range of different functions (<xref ref-type="fig" rid="fig2">Fig. 2 A</xref> and Table S1). Overexpression of ATF4 misregulates the expression of 149 genes (<xref ref-type="fig" rid="fig2">Fig. 2 B</xref> and Table S2). 24 of these ATF4 target genes are also misregulated by TFAM overexpression, and their expression is highly correlated (<xref ref-type="fig" rid="fig2">Fig. 2, B and C</xref>; and Table S3), consistent with activation of ATF4 by neuronal mitochondrial stress (<xref ref-type="fig" rid="fig1">Fig. 1, A–D</xref>). Importantly, knockdown of ATF4 reverses ∼25% (22/87) of the transcriptional changes caused by TFAM overexpression (<xref ref-type="fig" rid="fig2">Fig. 2, A and D</xref>; and Tables S4 and S5; see Materials and methods), indicating that ATF4 is a key regulator of mitochondrial stress signaling in the <italic>Drosophila</italic> nervous system.</p>
<fig fig-type="figure" id="fig2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p><bold>Neuronal mitochondrial stress activates a transcriptional response via ATF4. (A)</bold> Venn diagrams showing the number of significantly misregulated genes in the control versus TFAM overexpression (o/e) and TFAM overexpression versus TFAM overexpression combined with ATF4 RNAi conditions as determined by RNA sequencing. ↑ = up-regulated; ↓ = down-regulated. <bold>(B)</bold> Venn diagrams showing the number of significantly misregulated genes in the control versus TFAM overexpression and control versus ATF4 overexpression conditions. <bold>(C)</bold> Gene expression correlations between genes significantly misregulated in both the control versus TFAM overexpression and control versus ATF4 overexpression conditions. <bold>(D)</bold> Gene expression correlations between genes significantly misregulated in both the control versus TFAM overexpression and TFAM overexpression versus TFAM overexpression combined with ATF4 RNAi conditions. FC, fold change. See Materials and methods and Tables S1, S2, S3, S4, and S5 for details.</p>
</caption>
<graphic xlink:href="JCB_201904148_Fig2"></graphic>
</fig>
<p>ATF4 regulates the expression of metabolic genes (<xref ref-type="bibr" rid="bib4">Bao et al., 2016</xref>), including lactate dehydrogenase (LDH; <italic>Impl3</italic>) in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib22">Lee et al., 2015</xref>). Several of the genes whose expression is increased by TFAM overexpression but reversed by ATF4 knockdown are involved in glycolytic metabolism, including LDH (<italic>Impl3</italic>) and the trehalose transporter (<italic>Tret1-1</italic>; trehalose is the main circulating sugar in insects; <xref ref-type="fig" rid="fig2">Fig. 2 D</xref> and Table S5). To determine how mitochondrial stress affects neuronal metabolism, we performed metabolomic analysis using adult heads from flies with pan-neuronal TFAM overexpression. Pan-neuronal TFAM overexpression causes almost complete late pupal lethality (<xref ref-type="fig" rid="fig1">Fig. 1 G</xref>), so TFAM was pan-neuronally overexpressed in a <italic>TFAM<sup>c01716</sup></italic> loss-of-function heterozygous background, which produces viable adults. Analysis of global changes in metabolites shows that levels of 21 metabolites are altered by pan-neuronal TFAM overexpression (<xref ref-type="fig" rid="fig3">Fig. 3 A</xref>). Consistent with other mitochondrial stress models (<xref ref-type="bibr" rid="bib4">Bao et al., 2016</xref>; <xref ref-type="bibr" rid="bib20">Khan et al., 2017</xref>), serine and carnitine levels are increased in TFAM overexpressing tissue (<xref ref-type="fig" rid="fig3">Fig. 3 A</xref>). Grouping individual metabolites by metabolic pathway shows that levels of the TCA cycle intermediates α-ketoglutarate (α-KG) and fumarate are decreased (<xref ref-type="fig" rid="fig3">Fig. 3, B and C</xref>; and Table S6). The glycolytic pathway intermediates phosphoenolpyruvate, D-glyceraldehyde-3-phosphate, and the 3-phosphoglycerate precursor 2/3-phosphoglycerate are all decreased by TFAM overexpression, while lactate levels are increased (<xref ref-type="fig" rid="fig3">Fig. 3, D–F</xref>; and Table S6). These data provide evidence that mitochondrial stress causes defects in the TCA cycle and glycolytic metabolism in <italic>Drosophila</italic> neurons.</p>
<fig fig-type="figure" id="fig3" orientation="portrait" position="float">
<label>Figure 3.</label>
<caption>
<p><bold>Mitochondrial stress signaling increases 2-HG levels via ATF4.</bold>
<bold>(A)</bold> Metabolites whose levels are significantly changed (5% false discovery rate) in adult heads from flies with pan-neuronal TFAM overexpression (o/e) using <italic>nSyb-Gal4</italic>. <bold>(B–F)</bold> Levels of individual TCA cycle and glycolytic metabolites in adult heads from flies with pan-neuronal TFAM overexpression using <italic>nSyb-Gal4.</italic> See Table S6 for details. <bold>(G)</bold> Knockdown of ATF4 reduces the increase in 2-HG levels caused by pan-neuronal TFAM overexpression using <italic>nSyb-Gal4</italic>. Controls are <italic>nSyb-Gal4</italic> hemizygotes. Data are represented as mean ± SEM. <italic>n</italic> = 5 for all genotypes. ns, not significant; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001.</p>
</caption>
<graphic xlink:href="JCB_201904148_Fig3"></graphic>
</fig>
</sec>
<sec id="s5">
<title>Mitochondrial stress–induced 2-hydroxyglutarate (2-HG) is ATF4-dependent</title>
<p>Strikingly, the metabolite with the greatest fold change in TFAM overexpression tissue is 2-HG (<xref ref-type="fig" rid="fig3">Fig. 3 A</xref> and Table S6). L-2-HG is the predominant enantiomer of 2-HG in <italic>Drosophila</italic> and is synthesized from α-KG by the promiscuous activity of LDH (<xref ref-type="bibr" rid="bib23">Li et al., 2017</xref>). Since ATF4 knockdown reverses the mitochondrial stress–induced increase in LDH (<italic>Impl3</italic>) expression (<xref ref-type="fig" rid="fig2">Fig. 2 D</xref> and Table S5), we tested whether knockdown of ATF4 affects 2-HG levels. We find that knockdown of ATF4 significantly reduces the accumulation of 2-HG caused by TFAM overexpression (<xref ref-type="fig" rid="fig3">Fig. 3 G</xref>). Therefore, ATF4 regulates 2-HG levels in the nervous system during mitochondrial stress.</p>
</sec>
<sec id="s6">
<title>L-2-HG regulates neuronal function</title>
<p>The ability of ATF4 knockdown to regulate 2-HG and alleviate the neuronal functional defects caused by TFAM overexpression suggested that 2-HG might contribute to neuronal dysfunction. LDH uses α-KG as a promiscuous substrate to produce L-2-HG, but L-2-HG is converted back to α-KG by the dedicated enzyme L-2-HG dehydrogenase (L-2-HGDH; <xref ref-type="bibr" rid="bib21">Kranendijk et al., 2012</xref>; <xref ref-type="bibr" rid="bib23">Li et al., 2017</xref>). A deficiency in L-2-HGDH in humans can lead to a disease known as L-2-hydroxyglutaric aciduria (L-2-HGA). L-2-HGA is a rare neurodegenerative disorder that causes hypotonia, tremors, epilepsy, delayed brain development, and psychomotor regression (<xref ref-type="bibr" rid="bib21">Kranendijk et al., 2012</xref>). Chiral derivitization confirmed that the predominant 2-HG enantiomer present in TFAM-overexpressing tissue is L-2-HG (Fig. S2). Measurement of 2-HG levels in fly heads overexpressing TFAM and with L-2-HGDH knockdown shows that the mitochondrial stress–induced increase in 2-HG is exacerbated by L-2-HGDH knockdown (<xref ref-type="fig" rid="fig4">Fig. 4 A</xref>). Functional assays show that knockdown of L-2-HGDH also exacerbates the climbing and wing inflation defects caused by TFAM overexpression (<xref ref-type="fig" rid="fig4">Fig. 4, B and C</xref>). Furthermore, overexpression of L-2-HGDH together with TFAM reduces 2-HG to control levels (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref>) and completely rescues the climbing and wing inflation defects caused by TFAM overexpression (<xref ref-type="fig" rid="fig4">Fig. 4, E and F</xref>). Therefore, mitochondrial stress–induced activation of ATF4 and the consequent increase in 2-HG cause neurological dysfunction in <italic>Drosophila</italic>.</p>
<fig fig-type="figure" id="fig4" orientation="portrait" position="float">
<label>Figure 4.</label>
<caption>
<p><bold>Mitochondrial stress–induced L-2-HG regulates neuronal function. (A)</bold> The increase in 2-HG levels caused by pan-neuronal TFAM overexpression (o/e) is exacerbated by L-2-HGDH knockdown. <italic>n</italic> = 6 for all genotypes. <bold>(B)</bold> L-2-HGDH knockdown enhances the climbing defect caused by pan-neuronal TFAM overexpression. Control <italic>n</italic> = 13, L-2-HGDH RNAi <italic>n</italic> = 13, TFAM overexpression <italic>n</italic> = 12, TFAM overexpression + L-2-HGDH RNAi <italic>n</italic> = 10. <bold>(C)</bold> L-2-HGDH knockdown enhances the wing inflation defect caused by pan-neuronal TFAM overexpression. Numbers of flies are shown in white. <bold>(D)</bold> L-2-HGDH overexpression prevents the increase in 2-HG levels caused by TFAM overexpression. <italic>n</italic> = 4 for all genotypes. <bold>(E)</bold> L-2-HGDH overexpression alleviates the climbing defect caused by pan-neuronal TFAM overexpression. Control <italic>n</italic> = 14, L-2-HGDH overexpression <italic>n</italic> = 11, TFAM overexpression <italic>n</italic> = 12, TFAM overexpression + L-2-HGDH overexpression <italic>n</italic> = 14. <bold>(F)</bold> L-2-HGDH overexpression alleviates the wing inflation defect caused by pan-neuronal TFAM overexpression. Numbers of flies are shown in white. <italic>nSyb</italic>-<italic>Gal4</italic> was used for pan-neuronal expression. Controls are <italic>nSyb-Gal4</italic> hemizygotes. Data are represented as mean ± SEM. n.s., not significant; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001.</p>
</caption>
<graphic xlink:href="JCB_201904148_Fig4"></graphic>
</fig>
</sec>
<sec id="s7">
<title>Mitochondrial stress disrupts calcium homeostasis and activates ATF4 via the ER UPR</title>
<p>ATF4 is regulated at the level of translation by phosphorylation of eukaryotic initiation factor 2α (eIF2α). Overexpression of TFAM causes increased levels of phospho-eIF2α (<xref ref-type="fig" rid="fig5">Fig. 5, A–C</xref>). In <italic>Drosophila</italic>, eIF2α can be phosphorylated by the kinases PERK and GCN2 (<xref ref-type="bibr" rid="bib29">Malzer et al., 2013</xref>). The mitochondrial stress–induced activation of ATF4 is abolished by knockdown of PERK, but not GCN2 (<xref ref-type="fig" rid="fig5">Fig. 5, D–H</xref>; and Fig. S3, A–O). The PERK pathway is a branch of the ER UPR. To determine whether mitochondrial stress activates other branches of the ER UPR, we used a construct that reports on alternative splicing of the transcription factor XBP1 (<xref ref-type="bibr" rid="bib37">Ryoo et al., 2007</xref>). XBP1 is a component of the IRE1 pathway and is alternatively spliced upon activation of the ER UPR. TFAM overexpression causes an increase in the alternative splicing of XBP1 (<xref ref-type="fig" rid="fig5">Fig. 5, I–K</xref>). Taken together, these data show that in <italic>Drosophila</italic> neurons, ATF4 activation, and the consequent increase in L-2-HG caused by mitochondrial stress are a result of activation of the ER UPR.</p>
<fig fig-type="figure" id="fig5" orientation="portrait" position="float">
<label>Figure 5.</label>
<caption>
<p><bold>Mitochondrial stress–induced activation of ATF4 via the ER UPR. (A–B′)</bold> Compared with controls (A and A′), overexpression of TFAM in larval motor neurons causes increased expression of phospho-eIF2α (P-eIF2α; B and B′). P-eIF2α in white in A and B and magenta in A′ and B′. CD8-GFP (green) marks motor neurons. <bold>(C)</bold> Quantification of P-eIF2α expression. Control <italic>n</italic> = 8, TFAM overexpression <italic>n</italic> = 12. <bold>(D–G′)</bold> Knockdown of PERK (RNAi line 42499) prevents the increase in ATF4 expression (white in D–G and magenta in D′–G′) caused by overexpression (o/e) of TFAM in larval motor neurons using <italic>OK371-Gal4</italic>. CD8-GFP expression (green) marks motor neurons. <bold>(H)</bold> Quantification of ATF4 expression. Control <italic>n</italic> = 12, PERK RNAi <italic>n</italic> = 8, TFAM overexpression <italic>n</italic> = 12, TFAM overexpression + PERK RNAi <italic>n</italic> = 12. <bold>(I–J′)</bold> Compared with controls (I and I′), overexpression of TFAM in larval motor neurons using <italic>OK371-Gal4</italic> causes increased expression of XBP1-GFP (J and J<bold>′</bold>). XBP1-GFP in white in I and J and green in I′ and J′. nLacZ (magenta) marks motor neurons. <bold>(K)</bold> Quantification of XBP1-GFP expression. Control <italic>n</italic> = 6, TFAM overexpression <italic>n</italic> = 11. <bold>(L)</bold> TFAM overexpression in larval motor neurons disrupts activity-dependent Ca<sup>2+</sup> buffering. Mean of traces for GCaMP6m fluorescence in motor neuron cell bodies (using <italic>OK371-Gal4</italic>) as TrpA1 channels were activated by 20-s on/off pulses of 25°C heat, as indicated by the horizontal black lines below the graph (line = heat on, space = heat off). Control = black trace (<italic>n</italic> = 5), TFAM overexpression = red trace (<italic>n</italic> = 5). Controls are <italic>Gal4</italic> hemizygotes. Data are represented as mean ± SEM. *, P ≤ 0.05; ***, P ≤ 0.001.</p>
</caption>
<graphic xlink:href="JCB_201904148_Fig5"></graphic>
</fig>
<p>Increased ROS can activate mitochondrial stress response pathways, including the ER UPR (<xref ref-type="bibr" rid="bib34">Quirós et al., 2016</xref>), but we previously showed that TFAM overexpression causes reduced glutathione redox potential in larval neurons (<xref ref-type="bibr" rid="bib7">Cagin et al., 2015</xref>). Consistent with this finding, pan-neuronal TFAM overexpression causes decreased hydrogen peroxide levels in adult heads, which is not modified by ATF4 knockdown (Fig. S3 P), indicating that increased ROS do not mediate mitochondrial stress signaling via ATF4 in <italic>Drosophila</italic> neurons.</p>
<p>Insight into the mechanism by which mitochondrial stress activates the ER UPR may come from examination of the shared functions of mitochondria and the ER. Both organelles have critical roles in Ca<sup>2+</sup> storage and buffering, and altered cellular Ca<sup>2+</sup> homeostasis activates the ER UPR (<xref ref-type="bibr" rid="bib32">Paillusson et al., 2016</xref>). To investigate whether mitochondrial stress disrupts cellular Ca<sup>2+</sup> handling in <italic>Drosophila</italic> neurons, GCaMP6 was used to measure cytosolic Ca<sup>2+</sup> in vivo. We find that TFAM overexpression does not alter basal cytosolic Ca<sup>2+</sup> levels (Fig. S3, Q–S). However, GCaMP6 fluorescence is significantly increased in TFAM-overexpressing neurons during repetitive evoked neuronal activity (<xref ref-type="fig" rid="fig5">Fig. 5 L</xref>). This demonstrates that mitochondrial stress disrupts Ca<sup>2+</sup> flux, and is therefore a potential mechanism by which the ER UPR and ATF4 are activated in <italic>Drosophila</italic> neurons.</p>
<p>Mitochondrial stress activates signaling pathways that enable mitochondria to control nuclear gene expression and cellular metabolism (<xref ref-type="bibr" rid="bib16">Hunt and Bateman, 2018</xref>; <xref ref-type="bibr" rid="bib30">Mehta et al., 2017</xref>). We have shown that in the <italic>Drosophila</italic> nervous system, mitochondrial stress disrupts Ca<sup>2+</sup> homeostasis and triggers the ER UPR, resulting in activation of ATF4. ATF4 is a key element of the mitochondrial stress transcriptional response and reprograms neuronal metabolism. One result of the ATF4-dependent switch in metabolism is an increase in L-2-HG. Under conditions of mitochondrial stress, decreasing L-2-HG levels improves neuronal function, while increasing L-2-HG levels exacerbates neuronal dysfunction. Therefore, mitochondrial stress–induced L-2-HG regulates neuronal function in <italic>Drosophila</italic>.</p>
<p>The mitochondrial stress–induced increase in L-2-HG is conserved in other <italic>Drosophila</italic> models, mammalian cellular models, and patients with respiratory chain deficiency. Mutation of <italic>Pink1</italic>, which regulates mitochondrial quality control and is mutated in early onset familial Parkinson’s disease, or the mitochondrial citrate carrier gene <italic>scheggia</italic> in <italic>Drosophila</italic>, cause increased 2-HG (<xref ref-type="bibr" rid="bib24">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Tufi et al., 2014</xref>). 2-HG levels are also increased by loss of the complex III subunit Rieske iron-sulfur protein in mouse regulatory T cells, and L-2-HG is increased in cells from patients with a form of the mitochondrial disease Leigh syndrome (<xref ref-type="bibr" rid="bib2">Ansó et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Burr et al., 2016</xref>; <xref ref-type="bibr" rid="bib43">Weinberg et al., 2019</xref>). Metabolomic analysis has also shown that patients with mutations in respiratory chain complex I, complex III, or multiple complex deficiencies have increased 2-HG levels (<xref ref-type="bibr" rid="bib36">Reinecke et al., 2012</xref>).</p>
<p>L-2-HG inhibits α-KG–dependent oxygenases, such as the histone lysine demethylase JMJD2A and hypoxia-inducible factor prolyl hydroxylases, and so has wide-ranging effects on cell physiology (<xref ref-type="bibr" rid="bib6">Burr et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Chowdhury et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Losman and Kaelin, 2013</xref>). In addition, L-2-HG can bind to and inhibit mitochondrial ATP synthase, indirectly inhibiting mechanistic target of rapamycin signaling (<xref ref-type="bibr" rid="bib13">Fu et al., 2015</xref>). In<italic> Caenorhabditis elegans</italic>, the moderate inhibition of mitochondrial function and mechanistic target of rapamycin signaling caused by increased L-2-HG results in extended lifespan (<xref ref-type="bibr" rid="bib13">Fu et al., 2015</xref>). However, mice that are mutant for <italic>L-2-HGDH</italic> have high levels of L-2-HG in the brain, white matter abnormalities, and late-onset neurodegeneration (<xref ref-type="bibr" rid="bib28">Ma et al., 2017</xref>). Patients with L-2-HGA have progressive encephalopathy, particularly affecting the cerebellar white matter (<xref ref-type="bibr" rid="bib21">Kranendijk et al., 2012</xref>). The effects of high levels of L-2-HG are likely to be context-dependent, but neurons seem particularly sensitive to this metabolite. Our functional analyses suggest that modulating L-2-HG levels may be a potential therapeutic strategy for neurological diseases associated with mitochondrial dysfunction or persistent ATF4 activation.</p>
</sec>
</sec>
<sec id="s8" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s9">
<title>Fly strains and growth conditions</title>
<p>Flies were maintained on standard yeast, glucose, cornmeal, and agar food at 25°C in a 12-h light/dark cycle unless stated otherwise. Details of fly stocks are listed in Table S7. Fly stocks were from the Bloomington Drosophila Stock Center; the Vienna Drosophila Resource Center (<xref ref-type="bibr" rid="bib11">Dietzl et al., 2007</xref>); the NIG-Fly Stock Center, Japan; and FlyORF. Pan-neuronal TFAM overexpression causes late pupal lethality, so to obtain viable adults, TFAM was pan-neuronally overexpressed in a <italic>TFAM</italic> loss-of-function heterozygous mutant background (<italic>nSyb-Gal4, TFAM<sup>c01716</sup></italic>). For imaging experiments, embryos were laid over a 24-h period at 25°C, incubated for a further 24 h at 25°C, and then incubated at 29°C for 3 d before analysis, unless stated otherwise.</p>
</sec>
<sec id="s10">
<title>Behavioral analysis</title>
<p>For all assays using flies with neuronal dysfunction, vials were placed on their sides during eclosion to prevent flies from becoming stuck in the food. For climbing assays, male flies of appropriate genotype were selected under CO<sub>2</sub> anesthesia, within 24 h of eclosion. Assays were undertaken 24–48 h later to allow the flies to recover from the anesthetic, 1–3 h after morning illumination. Individual flies were aspirated from a vial into a 10-ml serological pipette (Falcon). Flies were relocated to the base of the pipette by tapping against the bench. The height obtained in three continuous 10-s climbs was measured for each fly, and the mean computed to give the data point for that insect. Wandering (i.e., nonvertical) or discontinuous climbs were excluded.</p>
<p>For wing inflation assays, all flies that eclosed from each cross were collected under CO<sub>2</sub> anesthesia, and stored at 25°C for ≥24 h to ensure that an uninflated wing phenotype was not due to young age. The numbers of flies with inflated, semi-inflated, and uninflated wings were then counted.</p>
<p>Viability assays were performed by counting the number of pupae containing flies that failed to eclose and empty pupal cases from which viable flies has successfully eclosed.</p>
</sec>
<sec id="s11">
<title>Immunofluorescence and imaging</title>
<p>Images were taken using a Zeiss LSM710 confocal microscope with Zen 2012 LSM software or a Nikon A1R confocal microscope with NIS Elements software, as described below. Images were taken at room temperature unless stated otherwise. Imaging of controls and experimental samples in each experiment was performed using identical confocal microscope settings.</p>
<p>For larval CNS imaging, fly crosses were left to egg-lay at 25°C for 3 d. The adults were then removed and the embryos incubated at 29°C (to enhance Gal4 activity) until dissection at the third instar larval stage. For fixed CNS tissue imaging, larvae were removed from their vials, cleaned in ice-cold PBS (Oxoid; Thermo Fisher Scientific), and then transferred to a drop of PBS on a Sylgard plate. The larvae were bisected with forceps (Agar Scientific) and the mouth end retained in the PBS. The cuticle was then inverted by coaxing the open end of the larvae over forceps holding the mouth parts. After the viscera was removed, the inverted cuticle with attached CNS was transferred to a 0.5-ml Eppendorf and fixed for 25 min in 4% formaldehyde (Thermo Fisher Scientific)/PBS. After three 10-min washes with 0.1% Triton X-100 (Sigma-Aldrich)/PBS (PBS-T), the samples were blocked for 1 h in 5% normal goat serum (Yorlab)/PBS-T. The relevant primary antibodies were applied in 5% normal goat serum/PBS-T and left rocking overnight at 4°C. After three further 10-min PBS-T washes, the samples were incubated with secondary antibody/PBS-T at room temperature for 1 h, and then washed 2× with PBS-T and 1× with PBS (10 min per wash). The samples were then transferred in PBS onto SuperFrost Plus microscope slides (Thermo Fisher Scientific), where the cuticle was removed and the CNS mounted dorsal side up in Vectashield (Vector Laboratories) under 22 × 22-mm size-0 coverslips (Academy). The slides were stored at 4°C in the dark. Images were taken on a Zeiss LSM710 confocal microscope with an EC Plan Neofluar 40× NA 1.3 oil immersion lens.</p>
<p>For imaging adult brains, crosses were incubated at 25°C. 2–5 d after eclosion, each adult fly was briefly anaesthetized using CO<sub>2</sub>, then immobilized ventral side up with a micro-pin (Entomoravia) through the thorax on Sylgard in PBS. Adult brains were then dissected using fine tweezers, fixed for 30 min in 4% formaldehyde (Thermo Fisher Scientific)/PBS, and stained in the same way as larval CNS tissue. Images were taken using a Nikon A1R confocal microscope with a CFI PLAN APO VC 20× NA 0.75 lens.</p>
<p>Primary antibodies were P-eIF2α (1:500; rabbit anti-phospho-eIF2α [Ser51]; Cell Signaling Technology 9721), ATF4 (1:250; rat; this study), β-gal (1:1,000; mouse anti-β-galactosidase; Z378A; Promega). Secondary antibodies were goat anti-mouse Alexa Fluor 633 (A21052; Invitrogen), goat anti-rabbit Alexa Fluor 546 (A11035; Invitrogen), goat anti-rat Alexa Fluor 555 (A21434; Thermo Fisher Scientific), and Cy5 AffiniPure donkey anti-rat (JIR 712-175-153).</p>
<p>For quantification of fixed immunostained tissue with membrane marker (CD8-GFP), maximum intensity projections of z-stacks through the dorsal side of the ventral nerve cord were obtained in ImageJ. 50 points in the nuclear or cytoplasmic region of interest were then selected in the marker channel (CD8-GFP) without reference to the channel of interest. The average fluorescence intensity of those 50 points was then obtained in the channel of interest.</p>
<p>For basal GCaMP6m imaging, larvae were dissected in Schneider’s medium (Sigma-Aldrich) and the CNS then transferred to a SuperFrost Plus microscope slide (Thermo Fisher Scientific). A coverslip was applied with 15 µl of Schneider’s underneath to hydrate the sample and sealed with nail polish. z-Stacks were taken with a Zeiss LSM710 confocal microscope, a 20×, NA 0.8 Plan Apochromat objective, using the 488 nm laser, with 1-µm inter-slice intervals. Maximum intensity projections were created in ImageJ. 50 points were selected in fluorescent regions, and the average of those points was computed to give the mean fluorescence for each sample.</p>
<p>For thermogenetically stimulated GCaMP6m imaging, wandering third instar larvae were bisected and the cuticle inverted in hemolymph-like 3.1 (HL3.1) media (70 mM NaCl, 5 mM KCl [Thermo Fisher Scientific], 1.5 mM CaCl<sub>2</sub> [Sigma-Aldrich], 4 mM MgCl<sub>2</sub> [Sigma-Aldrich], 10 mM NaHCO<sub>3</sub> [Life Technologies], 5 mM Trehalose [Thermo Fisher Scientific], 115 mM sucrose [Sigma-Aldrich], and 5 mM Hepes [Alfa Aesar]). The CNS was dissected from the inverted cuticle and retained on the microscope slide in residual HL3.1. A 1-mm-thick, 10-mm–external diameter rubber O-ring was placed around the CNS to serve as a mold for the agarose that was used to immobilize the sample during imaging. The O-ring was flooded with molten 1% low-melt agarose (2-hydroxyethyl agarose [Sigma-Aldrich] in HL3.1 media) ejected from a P1000 pipette with sufficient force to carry the CNS to the surface of the agarose. The slide was then placed in the refrigerator for ∼5 min to allow the agarose to set, after which the O-ring was carefully removed and a 22 × 22-mm size-0 coverslip was placed directly onto the agarose. Activation of the TrpA1 channel was achieved via a peltier (Hebei TEC1-12706) secured flush underneath the microscope slide during imaging. The peltier was connected to the Thurlby Thandar PL154 powerpack (RS Components) and calibrated to ramp to a temperature of 25°C using an infrared thermometer (GM320; L-FENG-UK) pointed at the surface of the peltier while the voltage was adjusted. Time series were taken with a Zeiss LSM710 confocal microscope at 2 Hz using a 20×, NA 0.8, Plan Apochromat objective and a 488-nm laser. Times series were quantified by plotting the profile of 50 points (selected within the cell bodies) across each frame in ImageJ.</p>
</sec>
<sec id="s12">
<title>Amplex red assay</title>
<p>10 Snap-frozen adult fly heads were ground using a plastic pestle in 300 µl of Amplex red buffer (50 µM Amplex red [Thermo Fisher Scientific] and 1 U/ml HRP [Sigma-Aldrich] in PBS). Samples were incubated in the dark at 37°C for 1 h, with mixing every 15 min. Samples were then centrifuged at 14,000 rpm for 1 min, and 200 µl supernatant per well was added to a 96-well plate. Absorbance was read at 560 nm using a CLARIOstar microplate reader (BMG Labtech). For each genotype, five biological replicates were analyzed and the average absorbance was calculated.</p>
</sec>
<sec id="s13">
<title>ATF4 antibody creation</title>
<p>A 180-bp region common to all isoforms of <italic>Drosophila</italic> ATF4, but upstream of the conserved DNA binding domain, was amplified from genomic DNA using primers 5′-ATA​TT<underline>GGA​TCC</underline>GAA​TGT​CTT​TTG​GAC​CAA​AAG​GC-3′ and 5′-AGC​GA<underline>CTC​GAG</underline>AGC​CAT​CAT​TGA​GCT​GGT​AAT-3′, digested with BamHI and XhoI (enzyme sites underlined in primers) and cloned into pGEX4T-2 (Amersham). The ATF4-GST fusion protein was overexpressed in BL21 (DE3) cells and purified using glutathione sepharose beads (4B; GE Healthcare). Purified ATF4-GST was used to immunize Sprague Dawley rats (Envigo RMS UK) and generate antisera.</p>
</sec>
<sec id="s14">
<title>Quantitative RT-PCR (qRT-PCR)</title>
<p>qRT-PCR was performed as described previously (<xref ref-type="bibr" rid="bib7">Cagin et al., 2015</xref>) but using the following primers: ATF4 forward, 5′-ATT​CAC​TGC​TGC​CGC​AAA​A-3′; ATF4 reverse, 5′-GTT​CAA​CGT​TGC​CTT​TTG​GT-3′; Rpl4 forward, 5′-TCC​ACC​TTG​AAG​AAG​GGC​TA-3′; and Rpl4 reverse, 5′-TTG​CGG​ATC​TCC​TCA​GAC​TT-3′.</p>
</sec>
<sec id="s15">
<title>RNA sequencing transcriptomic analysis</title>
<p>For each replicate, 20 CNSs were dissected from third instar larvae in cold PBS and placed into 100 µl of lysis buffer + β-mercaptoethanol from the Absolutely RNA Microprep kit (Agilent Technologies). Each genotype was prepared in quadruplicate. RNA was extracted from the CNS tissue using the Absolutely RNA Microprep kit according to the manufacturer’s protocol. The samples were sent on dry ice to the Next-Generation Sequencing Laboratory at Glasgow Polyomics, where they prepared polyA cDNA libraries using the TruSeq Stranded mRNA kit (Illumina), and oversaw 75-bp single-end sequencing at a depth of 25 million reads on the Illumina NextSeq 500. The raw unaligned reads were received in fastq format and mapped to the <italic>Drosophila melanogaster</italic> dm6 genome using Bowtie2 (Galaxy Version 2.3.4.2) software (<xref ref-type="bibr" rid="bib40">Trapnell et al., 2012</xref>). Alignment quality was ≥92% overall read alignment for all samples. Raw fragment counts were generated from the BAM files via the featureCounts (Galaxy Version 1.6.3+galaxy2) program (<xref ref-type="bibr" rid="bib25">Liao et al., 2014</xref>) and fed into the DESeq2 program (Galaxy Version 2.11.40.6; <xref ref-type="bibr" rid="bib27">Love et al., 2014</xref>) to analyze differential gene expression. Bowtie2, featureCounts, and DESeq2 were all accessed via the web-based user interface software Galaxy (<ext-link ext-link-type="uri" xlink:href="http://usegalaxy.org">http://usegalaxy.org</ext-link>; <xref ref-type="bibr" rid="bib1">Afgan et al., 2018</xref>) using default settings. RNA sequencing data are deposited in the GEO repository under accession no. <ext-link ext-link-type="NCBI:geo" xlink:href="GSE128244">GSE128244</ext-link>.</p>
<p>A gene was considered to be significantly up- or down-regulated if the fold change was greater than or equal to ±1.2, the adjusted P value &lt;0.05 and the fragments per kilobase of transcript per million mapped reads ≥1 in at least one condition. The expression of a gene that was significantly up- or down-regulated by TFAM overexpression compared with control (Table S1) was considered to have been reversed by ATF4 knockdown (Table S5) if it showed significant, but opposite, regulation when the TFAM overexpression condition was compared with the TFAM overexpression combined with the ATF4 knockdown condition (Table S4).</p>
</sec>
<sec id="s16">
<title>Metabolomic analysis</title>
<p>20 2–5-d-old adult flies (equal numbers of males and females) were snap-frozen on liquid nitrogen in a 15-ml Falcon tube and then vortexed for 5 s five times to decapitate. Heads were then quickly separated and stored at −80°C. Soluble metabolites were extracted directly from tissue using cold methanol/water (80/20, vol/vol) at 1 µl per 10 µg of tissue. Tissue was disrupted for 15 s by ultrasonication (Branson Sonifier 250). Debris were pelleted by centrifugation at 18,000 × <italic>g</italic> for 15 min at 4°C. The supernatant was transferred to a new tube and evaporated to dryness using a SpeedVac concentrator (Thermo Fisher Scientific). Metabolites were reconstituted in 50% acetonitrile in analytical-grade water, vortex-mixed, and centrifuged to remove debris. Samples were analyzed by HPLC and high-resolution mass spectrometry and tandem mass spectrometry (MS/MS). Specifically, the system consisted of a Q-Exactive in line with an electrospray source and an Ultimate3000 (Thermo Fisher Scientific) series HPLC consisting of a binary pump, degasser, and auto-sampler outfitted with an Xbridge Amide column (dimensions of 4.6 × 100 mm and a 3.5-µm particle size; Waters). Mobile phase A contained 95% (vol/vol) water, 5% (vol/vol) acetonitrile, 10 mM ammonium hydroxide, and 10 mM ammonium acetate, pH 9.0; and mobile phase B was 100% acetonitrile. The gradient was as follows: 0 min, 15% A; 2.5 min, 30% A; 7 min, 43% A; 16 min, 62% A; 16.1–18 min, 75% A; 18–25 min, and 15% A with a flow rate of 400 µl/min. The capillary of the electrospray ionization (ESI) source was set to 275°C, with sheath gas at 45 arbitrary units, auxiliary gas at 5 arbitrary units, and the spray voltage at 4.0 kV. In positive/negative polarity switching mode, a mass-to-charge ratio scan range from 70 to 850 was chosen, and MS1 data were collected at a resolution of 70,000. The automatic gain control target was set at 10<sup>6</sup>, and the maximum injection time was 200 ms. The top five precursor ions were subsequently fragmented in a data-dependent manner, using the higher energy collisional dissociation cell set to 30% normalized collision energy in MS2 at a resolution power of 17,500. Resolution of enantiomers of 2-HG was accomplished by derivatization with diacetyl-L-tartaric anhydride (DATAN) in acetic acid after the above SpeedVac step and measured by HPLC-MS/MS as previously described (<xref ref-type="bibr" rid="bib31">Oldham and Loscalzo, 2016</xref>).</p>
<p>For separation of DATAN derivitized D- and L-2-HG, samples were analyzed by HPLC-MS/MS, which consisted of a TSQ in line with an electrospray source and an Vanquish (Thermo Fisher Scientific) series HPLC consisting of a binary pump, degasser, and auto-sampler outfitted with an Ascentis Express C18 colume (dimensions of 2.1 × 150 mm and a 2.7-µm particle size; Supelco). Liquid chromatography was performed using a 98% buffer A (water with 2 mM amonium formate, pH 3.5, adjusted by formic acid) and 2% buffer B (methanol) isocratic elution of 10 min per sample. In negative mode, the capillary of the ESI source was set to 325°C, with sheath gas at 50 arbitrary units, auxiliary gas at 10 arbitrary units, and the spray voltage at 2,500 V. S-lens values were 37 V and reactions monitored, and collision energies were mass-to-charge ratio 363.06 → 147.03 (20 V).</p>
<p>Data acquisition and analysis were performed by Xcalibur 4.1 software and Tracefinder 4.1 software, respectively (both from Thermo Fisher Scientific). The peak area for each detected metabolite was normalized by the total ion count. 2-HG chromatograms were generated with Xcalibur software with spectral smoothing algorithm boxcar 15.</p>
</sec>
<sec id="s17">
<title>Statistical analyses</title>
<p>GraphPad Prism (GraphPad Software) was used to create graphs and for statistical analysis. Pairwise comparisons were analyzed via unpaired two-tailed <italic>t</italic> test, with Welch’s correction applied if the variances of the samples were significantly different. Data requiring multiple comparisons were analyzed by parametric one-way ANOVA with Tukey’s post hoc test. Global metabolite analysis was performed using the two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli (<xref ref-type="bibr" rid="bib5">Benjamini et al., 2006</xref>), with a false discovery rate (Q) = 5%. χ<sup>2</sup> tests were used to analyze categorical data. P values &lt;0.05 were considered significant.</p>
</sec>
<sec id="s18">
<title>Online supplemental material</title>
<p>Fig. S1 shows ATF4 expression, control climbing and wing inflation assays, and ATF4 qRT-PCR. Fig. S2 shows that 2-HG measured in heads from flies with pan-neuronal TFAM overexpression is predominantly the L enantiomer. Fig. S3 shows that mitochondrial stress–induced ATF4 activation requires PERK but not GCN2. Table S1 shows genes misregulated by TFAM overexpression. Table S2 shows genes misregulated by ATF4 overexpression. Table S3 shows genes that are commonly regulated by TFAM overexpression and ATF4 overexpression. Table S4 shows genes whose expression is modified by ATF4 knockdown. Table S5 shows genes whose expression is reversed by ATF4 knockdown. Table S6 shows metabolomic analysis of adult heads from flies with pan-neuronal (nSyb-Gal4) TFAM overexpression, ATF4 knockdown, or TFAM overexpression together with ATF4 knockdown and controls. Table S7 shows details of <italic>Drosophila</italic> lines.</p>
</sec>
</sec>
<sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="d35e184"><caption><title>Reviewer comments</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="JCB_201904148_review_history.pdf"></media></supplementary-material>
<supplementary-material content-type="local-data" id="PMC_1">
<caption>
<title>Supplemental Materials (PDF)</title>
</caption>
<media mime-subtype="pdf" mimetype="application" xlink:href="JCB_201904148_sm.pdf"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="PMC_2">
<caption>
<title>Tables S1-S6 (ZIP)</title>
</caption>
<media mime-subtype="x-zip-compressed" mimetype="application" xlink:href="JCB_201904148_TablesS1-S6.zip"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>Stocks obtained from the Bloomington Drosophila Stock Center (National Institutes of Health P40OD018537), the Vienna Drosophila Resource Center, and FlyORF were used in this study. We are grateful to Jason Tennessen (Indiana University Bloominton, Bloomington, IN), Darren Williams (King’s College London, London, UK), and Rita Sousa-Nunes (King’s College London, London, UK) for fly stocks. We thank Peng Gao and the Robert H. Lurie Cancer Center Metabolomics Core at Northwestern University Feinberg School of Medicine for metabolomics analysis. We thank the Wohl Cellular Imaging Centre at King’s College London for help with light microscopy.</p>
<p>This work was funded by Alzheimer’s Research UK (ARUK-IRG2017A-2) to J.M. Bateman; L. Granat is supported by the UK Medical Research Council (MR/N013700/1) and King’s College London Medical Research Council Doctoral Training Partnership in Biomedical Sciences; R.J. Hunt was funded by a PhD studentship from the Guy’s and St Thomas’ Charity. N.S. Chandel and G.S. McElroy were supported by National Institutes of Health grants AG049665-04 and T32CA9560-32, respectively. According to the UK research councils’ Common Principles on Data Policy, all data supporting this study will be openly available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1083/jcb.201904148">https://doi.org/10.1083/jcb.201904148</ext-link>.</p>
<p>The authors declare no competing financial interests.</p>
<p>Author contributions: Conceptualization: N.S. Chandel and J.M. Bateman; Methodology: R.J. Hunt and G.S. McElroy; Investigation: R.J. Hunt, L. Granat, G.S. McElroy, R. Ranganathan, and J.M. Bateman; Writing – original draft preparation: J.M. Bateman; Writing – review and editing: N.S. Chandel and J.M. Bateman; Visualization: R.J. Hunt, L. Granat, G.S. McElroy, R. Ranganathan, and J.M. Bateman; Supervision: N.S. Chandel and J.M. Bateman; Funding acquisition: N.S. Chandel and J.M. Bateman.</p>
</ack>
<ref-list>
<ref id="bib1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Afgan</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Batut</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>van den Beek</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bouvier</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Cech</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Chilton</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Clements</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Coraor</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Grüning</surname><given-names>B.A.</given-names></name>, <etal></etal></person-group>
<year>2018</year>
<article-title>The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update</article-title>. <source/>Nucleic Acids Res.
<volume>46</volume>(<issue>W1</issue>):<fpage>W537</fpage>–<lpage>W544</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky379</pub-id><pub-id pub-id-type="pmid">29790989</pub-id></mixed-citation>
</ref>
<ref id="bib2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ansó</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Weinberg</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Diebold</surname><given-names>L.P.</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>B.J.</given-names></name>, <name name-style="western"><surname>Malinge</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schumacker</surname><given-names>P.T.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Steadman</surname><given-names>M.</given-names></name>, <etal></etal></person-group>
<year>2017</year>
<article-title>The mitochondrial respiratory chain is essential for haematopoietic stem cell function</article-title>. <source/>Nat. Cell Biol.
<volume>19</volume>:<fpage>614</fpage>–<lpage>625</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3529</pub-id><pub-id pub-id-type="pmid">28504706</pub-id></mixed-citation>
</ref>
<ref id="bib3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnould</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Michel</surname><given-names>S.</given-names></name>, and <name name-style="western"><surname>Renard</surname><given-names>P.</given-names></name></person-group>
<year>2015</year>
<article-title>Mitochondria Retrograde Signaling and the UPR mt: Where Are We in Mammals?</article-title>
<source/>Int. J. Mol. Sci.
<volume>16</volume>:<fpage>18224</fpage>–<lpage>18251</lpage>. <pub-id pub-id-type="doi">10.3390/ijms160818224</pub-id><pub-id pub-id-type="pmid">26258774</pub-id></mixed-citation>
</ref>
<ref id="bib4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bao</surname><given-names>X.R.</given-names></name>, <name name-style="western"><surname>Ong</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Goldberger</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Vafai</surname><given-names>S.B.</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>A.G.</given-names></name>, <name name-style="western"><surname>Marutani</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ichinose</surname><given-names>F.</given-names></name>, <etal></etal></person-group>
<year>2016</year>
<article-title>Mitochondrial dysfunction remodels one-carbon metabolism in human cells</article-title>. <source/>eLife.
<volume>5</volume>:<elocation-id>e10575</elocation-id>
<pub-id pub-id-type="doi">10.7554/eLife.10575</pub-id><pub-id pub-id-type="pmid">27307216</pub-id></mixed-citation>
</ref>
<ref id="bib5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benjamini</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Krieger</surname><given-names>A.M.</given-names></name>, and <name name-style="western"><surname>Yekutieli</surname><given-names>D.</given-names></name></person-group>
<year>2006</year>
<article-title>Adaptive linear step-up procedures that control the false discovery rate</article-title>. <source/>Biometrika.
<volume>93</volume>:<fpage>491</fpage>–<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1093/biomet/93.3.491</pub-id></mixed-citation>
</ref>
<ref id="bib6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burr</surname><given-names>S.P.</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>A.S.</given-names></name>, <name name-style="western"><surname>Grice</surname><given-names>G.L.</given-names></name>, <name name-style="western"><surname>Timms</surname><given-names>R.T.</given-names></name>, <name name-style="western"><surname>Lobb</surname><given-names>I.T.</given-names></name>, <name name-style="western"><surname>Freisinger</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Dodd</surname><given-names>R.B.</given-names></name>, <name name-style="western"><surname>Dougan</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Lehner</surname><given-names>P.J.</given-names></name>, <name name-style="western"><surname>Frezza</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Nathan</surname><given-names>J.A.</given-names></name></person-group>
<year>2016</year>
<article-title>Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions</article-title>. <source/>Cell Metab.
<volume>24</volume>:<fpage>740</fpage>–<lpage>752</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2016.09.015</pub-id><pub-id pub-id-type="pmid">27923773</pub-id></mixed-citation>
</ref>
<ref id="bib7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cagin</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Duncan</surname><given-names>O.F.</given-names></name>, <name name-style="western"><surname>Gatt</surname><given-names>A.P.</given-names></name>, <name name-style="western"><surname>Dionne</surname><given-names>M.S.</given-names></name>, <name name-style="western"><surname>Sweeney</surname><given-names>S.T.</given-names></name>, and <name name-style="western"><surname>Bateman</surname><given-names>J.M.</given-names></name></person-group>
<year>2015</year>
<article-title>Mitochondrial retrograde signaling regulates neuronal function</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>112</volume>:<fpage>E6000</fpage>–<lpage>E6009</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1505036112</pub-id><pub-id pub-id-type="pmid">26489648</pub-id></mixed-citation>
</ref>
<ref id="bib8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Celardo</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Lehmann</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>A.C.</given-names></name>, <name name-style="western"><surname>Loh</surname><given-names>S.H.</given-names></name>, and <name name-style="western"><surname>Miguel Martins</surname><given-names>L.</given-names></name></person-group>
<year>2017</year>
<article-title>dATF4 regulation of mitochondrial folate-mediated one-carbon metabolism is neuroprotective</article-title>. <source/>Cell Death Differ.
<volume>24</volume>:<fpage>638</fpage>–<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2016.158</pub-id><pub-id pub-id-type="pmid">28211874</pub-id></mixed-citation>
</ref>
<ref id="bib9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Scarfe</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name></person-group>
<year>2019</year>
<article-title>Loss of <italic>Prune</italic> in Circadian Cells Decreases the Amplitude of the Circadian Locomotor Rhythm in <italic>Drosophila.</italic></article-title>
<source/>Front. Cell. Neurosci.
<volume>13</volume>:<fpage>76</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2019.00076</pub-id><pub-id pub-id-type="pmid">30881291</pub-id></mixed-citation>
</ref>
<ref id="bib10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chowdhury</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Yeoh</surname><given-names>K.K.</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>Y.M.</given-names></name>, <name name-style="western"><surname>Hillringhaus</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Bagg</surname><given-names>E.A.</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>N.R.</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>I.K.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.S.</given-names></name>, <name name-style="western"><surname>Woon</surname><given-names>E.C.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>M.</given-names></name>, <etal></etal></person-group>
<year>2011</year>
<article-title>The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases</article-title>. <source/>EMBO Rep.
<volume>12</volume>:<fpage>463</fpage>–<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1038/embor.2011.43</pub-id><pub-id pub-id-type="pmid">21460794</pub-id></mixed-citation>
</ref>
<ref id="bib11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dietzl</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Schnorrer</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>K.C.</given-names></name>, <name name-style="western"><surname>Barinova</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Fellner</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gasser</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Kinsey</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Oppel</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Scheiblauer</surname><given-names>S.</given-names></name>, <etal></etal></person-group>
<year>2007</year>
<article-title>A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila</article-title>. <source/>Nature.
<volume>448</volume>:<fpage>151</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1038/nature05954</pub-id><pub-id pub-id-type="pmid">17625558</pub-id></mixed-citation>
</ref>
<ref id="bib12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duncan</surname><given-names>O.F.</given-names></name>, <name name-style="western"><surname>Granat</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Ranganathan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>V.K.</given-names></name>, <name name-style="western"><surname>Mazaud</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Fanto</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Chambers</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Ballard</surname><given-names>C.G.</given-names></name>, and <name name-style="western"><surname>Bateman</surname><given-names>J.M.</given-names></name></person-group>
<year>2018</year>
<article-title>Ras-ERK-ETS inhibition alleviates neuronal mitochondrial dysfunction by reprogramming mitochondrial retrograde signaling</article-title>. <source/>PLoS Genet.
<volume>14</volume>:<elocation-id>e1007567</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1007567</pub-id><pub-id pub-id-type="pmid">30059502</pub-id></mixed-citation>
</ref>
<ref id="bib13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Chin</surname><given-names>R.M.</given-names></name>, <name name-style="western"><surname>Vergnes</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Pai</surname><given-names>M.Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ta</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Fazlollahi</surname><given-names>F.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling</article-title>. <source/>Cell Metab.
<volume>22</volume>:<fpage>508</fpage>–<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.06.009</pub-id><pub-id pub-id-type="pmid">26190651</pub-id></mixed-citation>
</ref>
<ref id="bib14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hallberg</surname><given-names>B.M.</given-names></name>, and <name name-style="western"><surname>Larsson</surname><given-names>N.G.</given-names></name></person-group>
<year>2011</year>
<article-title>TFAM forces mtDNA to make a U-turn</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>18</volume>:<fpage>1179</fpage>–<lpage>1181</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2167</pub-id><pub-id pub-id-type="pmid">22056802</pub-id></mixed-citation>
</ref>
<ref id="bib15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Mallucci</surname><given-names>G.R.</given-names></name></person-group>
<year>2019</year>
<article-title>The unfolded protein response in neurodegenerative disorders - therapeutic modulation of the PERK pathway</article-title>. <source/>FEBS J.
<volume>286</volume>:<fpage>342</fpage>–<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1111/febs.14422</pub-id><pub-id pub-id-type="pmid">29476642</pub-id></mixed-citation>
</ref>
<ref id="bib16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunt</surname><given-names>R.J.</given-names></name>, and <name name-style="western"><surname>Bateman</surname><given-names>J.M.</given-names></name></person-group>
<year>2018</year>
<article-title>Mitochondrial retrograde signaling in the nervous system</article-title>. <source/>FEBS Lett.
<volume>592</volume>:<fpage>663</fpage>–<lpage>678</lpage>. <pub-id pub-id-type="doi">10.1002/1873-3468.12890</pub-id><pub-id pub-id-type="pmid">29086414</pub-id></mixed-citation>
</ref>
<ref id="bib17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Vasudevan</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Neubert</surname><given-names>T.A.</given-names></name>, <name name-style="western"><surname>Marr</surname><given-names>M.T.</given-names><suffix>II</suffix></name>, and <name name-style="western"><surname>Ryoo</surname><given-names>H.D.</given-names></name></person-group>
<year>2017</year>
<article-title>4E-BP is a target of the GCN2-ATF4 pathway during Drosophila development and aging</article-title>. <source/>J. Cell Biol.
<volume>216</volume>:<fpage>115</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201511073</pub-id><pub-id pub-id-type="pmid">27979906</pub-id></mixed-citation>
</ref>
<ref id="bib18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>C.T.</given-names></name>, and <name name-style="western"><surname>Kaufman</surname><given-names>B.A.</given-names></name></person-group>
<year>2018</year>
<article-title>The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms</article-title>. <source/>FEBS Lett.
<volume>592</volume>:<fpage>793</fpage>–<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1002/1873-3468.12989</pub-id><pub-id pub-id-type="pmid">29364506</pub-id></mixed-citation>
</ref>
<ref id="bib19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khacho</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>R.</given-names></name>, and <name name-style="western"><surname>Slack</surname><given-names>R.S.</given-names></name></person-group>
<year>2019</year>
<article-title>Mitochondria as central regulators of neural stem cell fate and cognitive function</article-title>. <source/>Nat. Rev. Neurosci.
<volume>20</volume>:<fpage>34</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1038/s41583-018-0091-3</pub-id><pub-id pub-id-type="pmid">30464208</pub-id></mixed-citation>
</ref>
<ref id="bib20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>N.A.</given-names></name>, <name name-style="western"><surname>Nikkanen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yatsuga</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Pradhan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kivela</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Pessia</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Velagapudi</surname><given-names>V.</given-names></name>, and <name name-style="western"><surname>Suomalainen</surname><given-names>A.</given-names></name></person-group>
<year>2017</year>
<article-title>mTORC1 Regulates Mitochondrial Integrated Stress Response and Mitochondrial Myopathy Progression</article-title>. <source/>Cell Metab.
<volume>26</volume>:<fpage>419</fpage>–<lpage>428.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2017.07.007</pub-id><pub-id pub-id-type="pmid">28768179</pub-id></mixed-citation>
</ref>
<ref id="bib21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kranendijk</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Struys</surname><given-names>E.A.</given-names></name>, <name name-style="western"><surname>Salomons</surname><given-names>G.S.</given-names></name>, <name name-style="western"><surname>Van der Knaap</surname><given-names>M.S.</given-names></name>, and <name name-style="western"><surname>Jakobs</surname><given-names>C.</given-names></name></person-group>
<year>2012</year>
<article-title>Progress in understanding 2-hydroxyglutaric acidurias</article-title>. <source/>J. Inherit. Metab. Dis.
<volume>35</volume>:<fpage>571</fpage>–<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1007/s10545-012-9462-5</pub-id><pub-id pub-id-type="pmid">22391998</pub-id></mixed-citation>
</ref>
<ref id="bib22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Oney</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Frizzell</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Phadnis</surname><given-names>N.</given-names></name>, and <name name-style="western"><surname>Hollien</surname><given-names>J.</given-names></name></person-group>
<year>2015</year>
<article-title>Drosophila melanogaster activating transcription factor 4 regulates glycolysis during endoplasmic reticulum stress</article-title>. <source/>G3 (Bethesda).
<volume>5</volume>:<fpage>667</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1534/g3.115.017269</pub-id><pub-id pub-id-type="pmid">25681259</pub-id></mixed-citation>
</ref>
<ref id="bib23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Chawla</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Hurlburt</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Sterrett</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Zaslaver</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Karty</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Rosebrock</surname><given-names>A.P.</given-names></name>, <name name-style="western"><surname>Caudy</surname><given-names>A.A.</given-names></name>, and <name name-style="western"><surname>Tennessen</surname><given-names>J.M.</given-names></name></person-group>
<year>2017</year>
<article-title>Drosophila larvae synthesize the putative oncometabolite L-2-hydroxyglutarate during normal developmental growth</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>114</volume>:<fpage>1353</fpage>–<lpage>1358</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1614102114</pub-id><pub-id pub-id-type="pmid">28115720</pub-id></mixed-citation>
</ref>
<ref id="bib24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hurlburt</surname><given-names>A.J.</given-names></name>, and <name name-style="western"><surname>Tennessen</surname><given-names>J.M.</given-names></name></person-group>
<year>2018</year>
<article-title>A <italic>Drosophila</italic> model of combined D-2- and L-2-hydroxyglutaric aciduria reveals a mechanism linking mitochondrial citrate export with oncometabolite accumulation</article-title>. <source/>Dis. Model. Mech.
<volume>11</volume>:<elocation-id>dmm035337</elocation-id>
<pub-id pub-id-type="doi">10.1242/dmm.035337</pub-id><pub-id pub-id-type="pmid">30108060</pub-id></mixed-citation>
</ref>
<ref id="bib25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Smyth</surname><given-names>G.K.</given-names></name>, and <name name-style="western"><surname>Shi</surname><given-names>W.</given-names></name></person-group>
<year>2014</year>
<article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>. <source/>Bioinformatics.
<volume>30</volume>:<fpage>923</fpage>–<lpage>930</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></mixed-citation>
</ref>
<ref id="bib26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Losman</surname><given-names>J.A.</given-names></name>, and <name name-style="western"><surname>Kaelin</surname><given-names>W.G.</given-names><suffix>Jr</suffix></name></person-group>
<year>2013</year>
<article-title>What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer</article-title>. <source/>Genes Dev.
<volume>27</volume>:<fpage>836</fpage>–<lpage>852</lpage>. <pub-id pub-id-type="doi">10.1101/gad.217406.113</pub-id><pub-id pub-id-type="pmid">23630074</pub-id></mixed-citation>
</ref>
<ref id="bib27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Love</surname><given-names>M.I.</given-names></name>, <name name-style="western"><surname>Huber</surname><given-names>W.</given-names></name>, and <name name-style="western"><surname>Anders</surname><given-names>S.</given-names></name></person-group>
<year>2014</year>
<article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source/>Genome Biol.
<volume>15</volume>:<fpage>550</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></mixed-citation>
</ref>
<ref id="bib28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>W.</given-names></name>, <etal></etal></person-group>
<year>2017</year>
<article-title><italic>L2hgdh</italic> Deficiency Accumulates l-2-Hydroxyglutarate with Progressive Leukoencephalopathy and Neurodegeneration</article-title>. <source/>Mol. Cell. Biol.
<volume>37</volume>:<elocation-id>e00492-16</elocation-id>
<pub-id pub-id-type="doi">10.1128/MCB.00492-16</pub-id><pub-id pub-id-type="pmid">28137912</pub-id></mixed-citation>
</ref>
<ref id="bib29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malzer</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Szajewska-Skuta</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dalton</surname><given-names>L.E.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Skaer</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lomas</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Crowther</surname><given-names>D.C.</given-names></name>, and <name name-style="western"><surname>Marciniak</surname><given-names>S.J.</given-names></name></person-group>
<year>2013</year>
<article-title>Coordinate regulation of eIF2α phosphorylation by PPP1R15 and GCN2 is required during Drosophila development</article-title>. <source/>J. Cell Sci.
<volume>126</volume>:<fpage>1406</fpage>–<lpage>1415</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.117614</pub-id><pub-id pub-id-type="pmid">23418347</pub-id></mixed-citation>
</ref>
<ref id="bib30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehta</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Weinberg</surname><given-names>S.E.</given-names></name>, and <name name-style="western"><surname>Chandel</surname><given-names>N.S.</given-names></name></person-group>
<year>2017</year>
<article-title>Mitochondrial control of immunity: beyond ATP</article-title>. <source/>Nat. Rev. Immunol.
<volume>17</volume>:<fpage>608</fpage>–<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2017.66</pub-id><pub-id pub-id-type="pmid">28669986</pub-id></mixed-citation>
</ref>
<ref id="bib31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oldham</surname><given-names>W.M.</given-names></name>, and <name name-style="western"><surname>Loscalzo</surname><given-names>J.</given-names></name></person-group>
<year>2016</year>
<article-title>Quantification of 2-Hydroxyglutarate Enantiomers by Liquid Chromatography-mass Spectrometry</article-title>. <source/>Bio Protoc.
<volume>6</volume>:<elocation-id>e1908</elocation-id>
<pub-id pub-id-type="doi">10.21769/BioProtoc.1908</pub-id></mixed-citation>
</ref>
<ref id="bib32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paillusson</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Stoica</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gomez-Suaga</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>D.H.W.</given-names></name>, <name name-style="western"><surname>Mueller</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Miller</surname><given-names>C.C.J.</given-names></name></person-group>
<year>2016</year>
<article-title>There’s Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative Diseases</article-title>. <source/>Trends Neurosci.
<volume>39</volume>:<fpage>146</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2016.01.008</pub-id><pub-id pub-id-type="pmid">26899735</pub-id></mixed-citation>
</ref>
<ref id="bib33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pohjoismaki</surname><given-names>J.L.</given-names></name>, <name name-style="western"><surname>Wanrooij</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hyvarinen</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Goffart</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Holt</surname><given-names>I.J.</given-names></name>, <name name-style="western"><surname>Spelbrink</surname><given-names>J.N.</given-names></name>, and <name name-style="western"><surname>Jacobs</surname><given-names>H.T.</given-names></name></person-group>
<year>2006</year>
<article-title>Alterations to the expression level of mitochondrial transcription factor A, TFAM, modify the mode of mitochondrial DNA replication in cultured human cells</article-title>. <source/>Nucleic Acids Res.
<volume>34</volume>:<fpage>5815</fpage>–<lpage>5828</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkl703</pub-id><pub-id pub-id-type="pmid">17062618</pub-id></mixed-citation>
</ref>
<ref id="bib34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quirós</surname><given-names>P.M.</given-names></name>, <name name-style="western"><surname>Mottis</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>Auwerx</surname><given-names>J.</given-names></name></person-group>
<year>2016</year>
<article-title>Mitonuclear communication in homeostasis and stress</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>17</volume>:<fpage>213</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1038/nrm.2016.23</pub-id><pub-id pub-id-type="pmid">26956194</pub-id></mixed-citation>
</ref>
<ref id="bib35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quirós</surname><given-names>P.M.</given-names></name>, <name name-style="western"><surname>Prado</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Zamboni</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>D’Amico</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>R.W.</given-names></name>, <name name-style="western"><surname>Finley</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>S.P.</given-names></name>, and <name name-style="western"><surname>Auwerx</surname><given-names>J.</given-names></name></person-group>
<year>2017</year>
<article-title>Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals</article-title>. <source/>J. Cell Biol.
<volume>216</volume>:<fpage>2027</fpage>–<lpage>2045</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201702058</pub-id><pub-id pub-id-type="pmid">28566324</pub-id></mixed-citation>
</ref>
<ref id="bib36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reinecke</surname><given-names>C.J.</given-names></name>, <name name-style="western"><surname>Koekemoer</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>van der Westhuizen</surname><given-names>F.H.</given-names></name>, <name name-style="western"><surname>Louw</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Lindeque</surname><given-names>J.Z.</given-names></name>, <name name-style="western"><surname>Mienie</surname><given-names>L.J.</given-names></name>, and <name name-style="western"><surname>Smuts</surname><given-names>I.</given-names></name></person-group>
<year>2012</year>
<article-title>Metabolomics of urinary organic acids in respiratory chain deficiencies in children</article-title>. <source/>Metabolomics.
<volume>8</volume>:<fpage>264</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1007/s11306-011-0309-0</pub-id></mixed-citation>
</ref>
<ref id="bib37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryoo</surname><given-names>H.D.</given-names></name>, <name name-style="western"><surname>Domingos</surname><given-names>P.M.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>M.J.</given-names></name>, and <name name-style="western"><surname>Steller</surname><given-names>H.</given-names></name></person-group>
<year>2007</year>
<article-title>Unfolded protein response in a Drosophila model for retinal degeneration</article-title>. <source/>EMBO J.
<volume>26</volume>:<fpage>242</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601477</pub-id><pub-id pub-id-type="pmid">17170705</pub-id></mixed-citation>
</ref>
<ref id="bib38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spinelli</surname><given-names>J.B.</given-names></name>, and <name name-style="western"><surname>Haigis</surname><given-names>M.C.</given-names></name></person-group>
<year>2018</year>
<article-title>The multifaceted contributions of mitochondria to cellular metabolism</article-title>. <source/>Nat. Cell Biol.
<volume>20</volume>:<fpage>745</fpage>–<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1038/s41556-018-0124-1</pub-id><pub-id pub-id-type="pmid">29950572</pub-id></mixed-citation>
</ref>
<ref id="bib39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stros</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Launholt</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Grasser</surname><given-names>K.D.</given-names></name></person-group>
<year>2007</year>
<article-title>The HMG-box: a versatile protein domain occurring in a wide variety of DNA-binding proteins</article-title>. <source/>Cell. Mol. Life Sci.
<volume>64</volume>:<fpage>2590</fpage>–<lpage>2606</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-007-7162-3</pub-id><pub-id pub-id-type="pmid">17599239</pub-id></mixed-citation>
</ref>
<ref id="bib40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trapnell</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Goff</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Pertea</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Kelley</surname><given-names>D.R.</given-names></name>, <name name-style="western"><surname>Pimentel</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Salzberg</surname><given-names>S.L.</given-names></name>, <name name-style="western"><surname>Rinn</surname><given-names>J.L.</given-names></name>, and <name name-style="western"><surname>Pachter</surname><given-names>L.</given-names></name></person-group>
<year>2012</year>
<article-title>Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks</article-title>. <source/>Nat. Protoc.
<volume>7</volume>:<fpage>562</fpage>–<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2012.016</pub-id><pub-id pub-id-type="pmid">22383036</pub-id></mixed-citation>
</ref>
<ref id="bib41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsuyama</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Tsubouchi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Usui</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Imamura</surname><given-names>H.</given-names></name>, and <name name-style="western"><surname>Uemura</surname><given-names>T.</given-names></name></person-group>
<year>2017</year>
<article-title>Mitochondrial dysfunction induces dendritic loss via eIF2α phosphorylation</article-title>. <source/>J. Cell Biol.
<volume>216</volume>:<fpage>815</fpage>–<lpage>834</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201604065</pub-id><pub-id pub-id-type="pmid">28209644</pub-id></mixed-citation>
</ref>
<ref id="bib42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tufi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gandhi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>de Castro</surname><given-names>I.P.</given-names></name>, <name name-style="western"><surname>Lehmann</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Angelova</surname><given-names>P.R.</given-names></name>, <name name-style="western"><surname>Dinsdale</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Deas</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Plun-Favreau</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Nicotera</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Abramov</surname><given-names>A.Y.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson’s disease</article-title>. <source/>Nat. Cell Biol.
<volume>16</volume>:<fpage>157</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2901</pub-id><pub-id pub-id-type="pmid">24441527</pub-id></mixed-citation>
</ref>
<ref id="bib43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinberg</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Singer</surname><given-names>B.D.</given-names></name>, <name name-style="western"><surname>Steinert</surname><given-names>E.M.</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Mehta</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Martínez-Reyes</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Helmin</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Abdala-Valencia</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Sena</surname><given-names>L.A.</given-names></name>, <etal></etal></person-group>
<year>2019</year>
<article-title>Mitochondrial complex III is essential for suppressive function of regulatory T cells</article-title>. <source/>Nature.
<volume>565</volume>:<fpage>495</fpage>–<lpage>499</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0846-z</pub-id><pub-id pub-id-type="pmid">30626970</pub-id></mixed-citation>
</ref>
<ref id="bib44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ylikallio</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Tyynismaa</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Tsutsui</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ide</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Suomalainen</surname><given-names>A.</given-names></name></person-group>
<year>2010</year>
<article-title>High mitochondrial DNA copy number has detrimental effects in mice</article-title>. <source/>Hum. Mol. Genet.
<volume>19</volume>:<fpage>2695</fpage>–<lpage>2705</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq163</pub-id><pub-id pub-id-type="pmid">20413656</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>